A. Rachel Leheny
CIK 1484729 · CHIEF EXECUTIVE OFFICER · last filed 2026-04-07
A. Rachel Leheny is a CHIEF EXECUTIVE OFFICER who has filed 26 SEC Form 4 insider transactions across 4 companies since 2010. The most recent filing, for CALC, was dated Apr 7, 2026. Across all open-market trades the lifetime net is +$914.3K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $114.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$114.4K
4
26
$914.3K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CALC | CHIEF EXECUTIVE OFFICER | 131,926 | $0.87 | $114.4K | $85.1K | 19 | 2026-04-07 |
| CalciMedica, Inc. (SCPH) Delisted | CHIEF EXECUTIVE OFFICER | 197,154 | $5.67 | $1.12M | $79.2K | 3 | 2024-11-01 |
| CalciMedica, Inc. (GRAY) Delisted | Chief Executive Officer | 356,989 | $5.50 | $1.96M | $0 | 1 | 2023-03-22 |
| Anthera Pharmaceuticals Inc (ANTH) Delisted | Director | 1,423,896 | — | — | $750.0K | 3 | 2010-10-04 |
Recent Filings
26 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-07 | CALC | Grant (A) | — | $0 | EDGAR |
| 2025-07-21 | CALC | Buy (P) | +1,000 | $3.4K | EDGAR |
| 2025-07-15 | CALC | Buy (P) | +2,500 | $6.2K | EDGAR |
| 2025-06-26 | CALC | Grant (A) | — | $0 | EDGAR |
| 2025-04-25 | CALC | Grant (A) | — | $0 | EDGAR |
| 2024-11-01 | CalciMedica, Inc. (SCPH) Delisted | Buy (P) | +20,000 | $75.0K | EDGAR |
| 2024-08-28 | CalciMedica, Inc. (SCPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-08-27 | CalciMedica, Inc. (SCPH) Delisted | Buy (P) | +1,000 | $4.2K | EDGAR |
| 2024-04-22 | CALC | Grant (A) | — | $0 | EDGAR |
| 2024-01-25 | CALC | Grant (A) | +91,086 | $388.6K | EDGAR |